Australia markets closed

Ever Supreme Bio Technology Co., Ltd (6712.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
201.00+7.00 (+3.61%)
At close: 01:30PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
627,980
627,512
438,841
70,597
10,819
Cost of revenue
233,247
212,955
193,361
88,542
8,553
Gross profit
394,733
414,557
245,480
-17,945
2,266
Operating expenses
Research development
94,993
90,691
84,141
109,248
94,507
Selling general and administrative
40,639
40,071
45,137
29,913
43,246
Total operating expenses
135,632
130,762
129,278
139,161
137,753
Operating income or loss
259,101
283,795
116,202
-157,106
-135,487
Interest expense
357
510
618
778
582
Income before tax
404,114
264,103
396,821
-137,398
-119,620
Income tax expense
69,308
63,389
27,220
-30,569
-25,401
Income from continuing operations
334,806
200,714
369,601
-106,829
-94,219
Net income
373,781
200,714
369,601
-106,829
-94,219
Net income available to common shareholders
334,806
200,714
369,601
-106,829
-94,219
Basic EPS
-
2.68
4.96
-1.58
-1.39
Diluted EPS
-
2.66
4.91
-1.58
-1.39
Basic average shares
-
74,876
74,575
67,801
67,738
Diluted average shares
-
75,394
75,265
67,801
67,738